ESC Professional Premium Access

The next frontiers in innovative therapies

Event: ESC Congress 2022
Topic: Cardiovascular Disease in Special Populations
Session type: Official Joint Session
Date: 26 August 2022
Time: 08:30 - 10:00

Congress Session

Become an ESC Professional member to access this resource

Become a member

Already a member? Sign in

7 presentations in this session

Discoveries to bedside therapies.

Speaker: Professor N. Dib (Phoenix, US)

Interventional solutions for heart failure.

Speaker: Professor J. Lindenfeld (Nashville, US)

Lp(a): aspirations for treating aortic stenosis.

Speaker: Professor U. Landmesser (Berlin, DE)

Can we eradicate atherosclerosis?

Speaker: Professor E. Braunwald (Boston, US)

Innovation in diagnosis and treatment of HFpEF.

Speaker: Professor I. Pina (Philadelphia, US)

Myosin inhibitors for treatment of hypertrophic obstructive cardiomyopathy.

Speaker: Doctor M. Desai (Cleveland, US)

The next frontiers in innovative therapies – discussion.


6 speakers from this session

Professor Nabil Dib

Mercy Gilbert Medical Centre, Phoenix (United States of America)
5 presentations
0 follower

Professor Joann Lindenfeld

Vanderbilt University, Nashville (United States of America)
9 presentations

Professor Ulf Landmesser

Charite University Hospital, Berlin (Germany)
36 presentations
1 follower

Professor Eugene Braunwald

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
33 presentations
1 follower

Professor Ileana Pina

Thomas Jefferson University, Philadelphia (United States of America)
22 presentations

Doctor Milind Desai

Cleveland Clinic Foundation, Cleveland (United States of America)
13 presentations
0 follower

This platform is supported by

logo Novo Nordisk